Source
Author: unknown
Eli Lilly to buy genetic medicine developer Akouos for $487 million [Deals Market Headlines | Breaking Stock Market News | Reuters]
Related Posts
Shionogi Buys IntraBio for $2 Billion to Acquire Approved Rare Disease Drug
Shionogi & Co., Ltd. agreed to acquire IntraBio Inc. for $2.0 billion in an all-cash transaction announced on October 5, 2026. The Japanese pharmaceutical company will purchase 100 percent of the...
GE HealthCare Acquires SOFIE Biosciences for $945 Million to Secure Radiopharmaceutical Supply Chain
GE HealthCare announced on October 5, 2026, that it agreed to purchase SOFIE Biosciences from private equity firm Trilantic North America for $945 million in cash. SOFIE Biosciences operates as a...
UK Private Hospital Giant Spire Agrees to £1.03 Billion Buyout Led by Toscafund
Spire Healthcare Group agreed on September 5, 2026, to a £1.03 billion cash takeover by Tulip UK Bidco, an investment consortium led by hedge fund manager Toscafund Asset Management alongside THCP...
AbbVie Solidifies Immunology Dominance with $10.9 Billion Acquisition of Apogee Therapeutics
AbbVie (NYSE: ABBV) today announced the successful completion of its acquisition of Apogee Therapeutics (NASDAQ: APGE), an all-cash transaction valued at approximately $10.9 billion. Under the terms...